| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Mar 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 30.62 | 2,674 | 81.88 k | 1,292,987 |
| 5 Mar 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 29.98 | 7,326 | 219.63 k | 1,295,661 |
| 5 Feb 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 40.58 | 15,000 | 608.70 k | 1,302,987 |
| 31 Jan 25 | APGE Apogee Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 22.86 | 8,500 | 194.31 k | 1,317,987 |
| 31 Jan 25 | APGE Apogee Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 22.86 | 8,500 | 194.31 k | 390,012 |
| 10 Jan 25 | SYRE Spyre Therapeutics | Common Stock | Other | Acquire J | No | No | 0 | 105,379 | 0.00 | 105,379 |
| 8 Jan 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 49.38 | 2,868 | 141.62 k | 1,309,487 |
| 8 Jan 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 48.72 | 12,132 | 591.07 k | 1,312,355 |
